Live Crown Castle Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Fulgent Genetics, Inc.

FLGT

Latest SEC Filings from Fulgent Genetics, Inc.

  1. 1
    1

    Fulgent Genetics Reports 4% Revenue Growth in Q2 2026, Operating Loss Increases

    via official filing (AI summary) 3 months ago 0 comments
  2. 2
    1

    Fulgent Genetics Reports $71.1 Million Revenue in Q1 2026, Acquires Bako Diagnostics

    via official filing (AI summary) 6 months ago 0 comments
  3. 3
    1

    Fulgent Genetics Reports $322.7 Million Revenue and $60.5 Million Net Loss for Fiscal Year 2025

    via official filing (AI summary) 8 months ago 0 comments
  4. 4
    1

    Fulgent Genetics Reports 17% Revenue Growth to $84.1 Million in Q3 2025

    via official filing (AI summary) 12 months ago 0 comments
  5. 5
    1

    Fulgent Genetics Reports 15% Revenue Growth in Q2 2025, Operating Loss Increases

    via official filing (AI summary) about 1 year ago 0 comments
  6. 6
    1

    Fulgent Genetics Reports 14% Revenue Growth to $73.5 Million in Q1 2025

    via official filing (AI summary) over 1 year ago 0 comments
  7. 7
    1

    Fulgent Genetics Reports $283.5M Revenue for Fiscal Year 2024, Net Loss Improves to $42.7M

    via official filing (AI summary) over 1 year ago 0 comments
  8. 8
    1

    Fulgent Genetics Reports Decline in Revenue and Operating Losses for Q3 and Nine Months of 2024

    via official filing (AI summary) almost 2 years ago 0 comments